TEGTOL CR-200
Formulation: Carbamazepine 200 mg
Use For: TEGTOL CR-200 contains Carbamazepine 200 mg in a controlled-release (CR) formulation, which helps to maintain stable blood levels and reduce the frequency of dosing. Carbamazepine is an anticonvulsant and mood stabilizer primarily used to treat epilepsy, trigeminal neuralgia, and bipolar disorder.
✅ TEGTOL CR-200 (Carbamazepine 200 mg)
TEGTOL CR-200 contains Carbamazepine 200 mg, a widely prescribed anticonvulsant and mood-stabilizing medication. It is used to treat epilepsy, bipolar disorder, and certain types of neuralgia (nerve pain). Carbamazepine works by stabilizing electrical activity in the brain and preventing abnormal electrical impulses that cause seizures and mood instability. This helps control seizures and prevent episodes of mood swings in bipolar disorder.
🔹 Therapeutic Uses:
Epilepsy (Seizure Disorders)
Partial seizures
Generalized tonic-clonic seizures
Mixed seizure types
Bipolar Disorder (Manic-Depressive Illness)
Trigeminal Neuralgia (nerve pain in the face)
Glossopharyngeal Neuralgia (pain in the throat area)
Neuropathic Pain Management
Prevention of seizures associated with other medical conditions
🔹 Mechanism of Action:
Carbamazepine works by blocking sodium channels in the brain, which reduces the excitability of neurons. This stabilization of neuronal activity helps to prevent seizures, manage mood swings, and alleviate nerve pain. It also increases the activity of certain neurotransmitters, contributing to its mood-stabilizing effects.
🔹 Advantages:
Effective control of seizures in various types of epilepsy
Mood stabilization for patients with bipolar disorder
Long-lasting effect with extended-release formulation (CR)
Helps with neuropathic pain such as trigeminal neuralgia
Low frequency of side effects when taken as directed
Reduces episodes of mania and depression in bipolar disorder
Convenient once or twice-a-day dosing due to the extended-release formulation
Proven efficacy for long-term management of epilepsy and mood disorders
🔹 For PCD Pharma Franchise:
We offer TEGTOL CR-200 (Carbamazepine 200 mg) under our PCD Pharma Franchise program, with the following benefits:
Monopoly marketing rights in your region
Affordable pricing with high-quality products
Comprehensive promotional support, including MR bags, visual aids, product samples, and literature
Attractive packaging for better market presence
Fast delivery to ensure timely stock replenishment
Regulatory documentation to comply with local regulations
Market expansion support to help you grow your business
🔹 For Third-Party Manufacturing:
We offer third-party manufacturing of TEGTOL CR-200 (Carbamazepine 200 mg) under your brand name with the following features:
WHO-GMP certified manufacturing facilities
Bulk production with your brand’s name and custom labeling
Private labeling and custom packaging options
Consistent quality control and adherence to global standards
Regulatory support for easy market approval and distribution
On-time delivery and fast shipping
Cost-effective pricing for long-term business partnerships
✅ Carbamazepine 200 mg
Carbamazepine 200 mg is an anticonvulsant and mood-stabilizing medication, widely used to manage epilepsy, bipolar disorder, and neuropathic pain. It works by stabilizing electrical activity in the brain, thus preventing seizures and controlling mood disorders. Carbamazepine is also effective in managing trigeminal neuralgia, a type of nerve pain, and other types of neuropathic pain.
🔹 Therapeutic Uses:
Epilepsy (Seizure Disorders)
Used for partial seizures and generalized tonic-clonic seizures.
Helps in managing both focal and generalized seizure types.
Bipolar Disorder
Used for mood stabilization, especially during manic episodes.
Reduces mood swings and episodes of aggression or irritability.
Trigeminal Neuralgia
Treats nerve pain that occurs along the trigeminal nerve, providing pain relief.
Neuropathic Pain
Helps manage nerve pain from conditions such as postherpetic neuralgia and other neuralgias.
🔹 Mechanism of Action:
Carbamazepine works by blocking sodium channels in the brain, stabilizing electrical activity and preventing excessive firing of neurons that lead to seizures. This helps manage both seizure activity and mood instability in patients with bipolar disorder. Additionally, it reduces the abnormal nerve signals in trigeminal neuralgia and other types of neuropathic pain.
🔹 Advantages:
Effective seizure control in epilepsy.
Mood stabilization for bipolar disorder, reducing manic and depressive episodes.
Pain relief from trigeminal neuralgia and other nerve pain conditions.
Long-lasting effect, ensuring reduced frequency of dosing (especially with extended-release formulations).
Fewer side effects when dosed appropriately.
Proven efficacy in long-term treatment for epilepsy, bipolar disorder, and neuropathic pain.
🔹 For PCD Pharma Franchise:
We offer Carbamazepine 200 mg under our PCD Pharma Franchise program with:
Monopoly rights for marketing.
Comprehensive promotional support, including MR bags, visual aids, product samples, and literature.
High-quality standards and affordable pricing.
Attractive packaging to enhance market visibility.
Timely delivery for inventory management.
Regulatory assistance to ensure compliance with local health authorities.
🔹 For Third-Party Manufacturing:
We provide third-party manufacturing for Carbamazepine 200 mg with:
WHO-GMP certified manufacturing facilities.
Custom labeling and packaging solutions.
Bulk production for private-label brands.
Strict quality control to meet international standards.
On-time delivery and regulatory support.
Competitive pricing for business partnerships.
KEYWORDS
Carbamazepine 200 mg, Carbamazepine CR, Carbamazepine for epilepsy, Carbamazepine for bipolar disorder, Carbamazepine for mood stabilization, Carbamazepine for seizure control, Carbamazepine for trigeminal neuralgia, Carbamazepine for neuropathic pain, Carbamazepine extended-release, Carbamazepine for generalized tonic-clonic seizures, Carbamazepine for partial seizures, Carbamazepine for mixed seizures, Carbamazepine for nerve pain, Carbamazepine for bipolar depression, Carbamazepine for acute mania, Carbamazepine for preventing seizures, Carbamazepine for treating epilepsy, Carbamazepine for nerve disorders, Carbamazepine for facial pain, Carbamazepine for glossopharyngeal neuralgia, Carbamazepine for epilepsy treatment, Carbamazepine for controlling seizures, Carbamazepine for seizure prevention, Carbamazepine for chronic pain, Carbamazepine for epilepsy control, Carbamazepine for mood disorder, Carbamazepine for manic episode, Carbamazepine for treating trigeminal neuralgia, Carbamazepine for treating seizures in children, Carbamazepine for controlling nerve pain, Carbamazepine for treating epilepsy in adults, Carbamazepine for reducing nerve pain, Carbamazepine for managing epilepsy, Carbamazepine for regulating mood swings, Carbamazepine for controlling seizures in epilepsy, Carbamazepine for treating facial pain, Carbamazepine for long-term epilepsy treatment, Carbamazepine for chronic seizure disorder, Carbamazepine for seizure relapse prevention, Carbamazepine for controlling epileptic attacks, Carbamazepine for pain management in trigeminal neuralgia, Carbamazepine for managing bipolar disorder, Carbamazepine for stress-induced epilepsy, Carbamazepine for reducing mania, Carbamazepine for controlling bipolar episodes, Carbamazepine for mood stability, Carbamazepine for preventing manic episodes, Carbamazepine for treating epilepsy in adults, Carbamazepine for managing epilepsy-related stress, Carbamazepine for reducing seizure frequency, Carbamazepine for generalized seizure prevention, Carbamazepine for reducing severe anxiety in bipolar disorder, Carbamazepine for managing chronic pain, Carbamazepine for sleep disturbances due to epilepsy, Carbamazepine for stabilizing mood swings, Carbamazepine for treating complex seizure types, Carbamazepine for improving quality of life in epilepsy, Carbamazepine for preventing seizure attacks, Carbamazepine for mood fluctuations in bipolar patients, Carbamazepine for psychiatric disorders, Carbamazepine for managing co-occurring mood disorders, Carbamazepine for alleviating symptoms of trigeminal neuralgia, Carbamazepine for treating neuropathic conditions, Carbamazepine for treating partial seizures, Carbamazepine for treating generalized tonic-clonic seizures, Carbamazepine for relieving pain due to neuralgia, Carbamazepine for mood disorder management, Carbamazepine for mood stabilization in bipolar patients, Carbamazepine for preventing episodic pain in trigeminal neuralgia, Carbamazepine for patients with epilepsy, Carbamazepine for acute pain relief, Carbamazepine for improving epilepsy prognosis, Carbamazepine for managing cognitive symptoms of epilepsy, Carbamazepine for epilepsy-induced stress relief, Carbamazepine for preventing panic attacks in epilepsy patients, Carbamazepine for stable treatment of chronic pain, Carbamazepine for safe management of bipolar disorder, Carbamazepine for reducing psychological impact of seizures, Carbamazepine for treating social anxiety in bipolar disorder, Carbamazepine for reducing recurrence of manic episodes, Carbamazepine for managing severe epilepsy symptoms, Carbamazepine for seizure relapse prevention, Carbamazepine for long-term epilepsy management, Carbamazepine for stable treatment of generalized seizures, Carbamazepine for managing facial nerve pain, Carbamazepine for long-term mood disorder treatment, Carbamazepine for pain relief, Carbamazepine for enhancing mental stability in bipolar disorder, Carbamazepine for preventing further nerve damage, Carbamazepine for improving overall patient health, Carbamazepine for controlling acute episodes of bipolar disorder, Carbamazepine for lowering risk of manic relapse, Carbamazepine for reducing facial nerve inflammation, Carbamazepine for managing post-traumatic epilepsy, Carbamazepine for stabilizing mood in treatment-resistant cases, Carbamazepine for improving seizure-free periods in epilepsy, Carbamazepine for helping with acute nerve pain, Carbamazepine for post-surgery nerve pain relief, Carbamazepine for reducing electrical activity in the brain, Carbamazepine for emotional stability in mental disorders, Carbamazepine for patients with severe psychiatric symptoms, Carbamazepine for improving mental health and quality of life, Carbamazepine for seizure activity management, Carbamazepine for controlling psychotic symptoms in bipolar disorder, Carbamazepine for easing discomfort from severe seizures, Carbamazepine for preventing mood swings and aggression in bipolar patients.Carbamazepine 200 mg, Carbamazepine CR, Carbamazepine for epilepsy, Carbamazepine for bipolar disorder, Carbamazepine for mood stabilization, Carbamazepine for seizure control, Carbamazepine for trigeminal neuralgia, Carbamazepine for neuropathic pain, Carbamazepine extended-release, Carbamazepine for generalized tonic-clonic seizures, Carbamazepine for partial seizures, Carbamazepine for mixed seizures, Carbamazepine for nerve pain, Carbamazepine for bipolar depression, Carbamazepine for acute mania, Carbamazepine for preventing seizures, Carbamazepine for treating epilepsy, Carbamazepine for nerve disorders, Carbamazepine for facial pain, Carbamazepine for glossopharyngeal neuralgia, Carbamazepine for epilepsy treatment, Carbamazepine for controlling seizures, Carbamazepine for seizure prevention, Carbamazepine for chronic pain, Carbamazepine for epilepsy control, Carbamazepine for mood disorder, Carbamazepine for manic episode, Carbamazepine for treating trigeminal neuralgia, Carbamazepine for treating seizures in children, Carbamazepine for controlling nerve pain, Carbamazepine for treating epilepsy in adults, Carbamazepine for reducing nerve pain, Carbamazepine for managing epilepsy, Carbamazepine for regulating mood swings, Carbamazepine for controlling seizures in epilepsy, Carbamazepine for treating facial pain, Carbamazepine for long-term epilepsy treatment, Carbamazepine for chronic seizure disorder, Carbamazepine for seizure relapse prevention, Carbamazepine for controlling epileptic attacks, Carbamazepine for pain management in trigeminal neuralgia, Carbamazepine for managing bipolar disorder, Carbamazepine for stress-induced epilepsy, Carbamazepine for reducing mania, Carbamazepine for controlling bipolar episodes, Carbamazepine for mood stability, Carbamazepine for preventing manic episodes, Carbamazepine for treating epilepsy in adults, Carbamazepine for managing epilepsy-related stress, Carbamazepine for reducing seizure frequency, Carbamazepine for generalized seizure prevention, Carbamazepine for reducing severe anxiety in bipolar disorder, Carbamazepine for managing chronic pain, Carbamazepine for sleep disturbances due to epilepsy, Carbamazepine for stabilizing mood swings, Carbamazepine for treating complex seizure types, Carbamazepine for improving quality of life in epilepsy, Carbamazepine for preventing seizure attacks, Carbamazepine for mood fluctuations in bipolar patients, Carbamazepine for psychiatric disorders, Carbamazepine for managing co-occurring mood disorders, Carbamazepine for alleviating symptoms of trigeminal neuralgia, Carbamazepine for treating neuropathic conditions, Carbamazepine for treating partial seizures, Carbamazepine for treating generalized tonic-clonic seizures, Carbamazepine for relieving pain due to neuralgia, Carbamazepine for mood disorder management, Carbamazepine for mood stabilization in bipolar patients, Carbamazepine for preventing episodic pain in trigeminal neuralgia, Carbamazepine for patients with epilepsy, Carbamazepine for acute pain relief, Carbamazepine for improving epilepsy prognosis, Carbamazepine for managing cognitive symptoms of epilepsy, Carbamazepine for epilepsy-induced stress relief, Carbamazepine for preventing panic attacks in epilepsy patients, Carbamazepine for stable treatment of chronic pain, Carbamazepine for safe management of bipolar disorder, Carbamazepine for reducing psychological impact of seizures, Carbamazepine for treating social anxiety in bipolar disorder, Carbamazepine for reducing recurrence of manic episodes, Carbamazepine for managing severe epilepsy symptoms, Carbamazepine for seizure relapse prevention, Carbamazepine for long-term epilepsy management, Carbamazepine for stable treatment of generalized seizures, Carbamazepine for managing facial nerve pain, Carbamazepine for long-term mood disorder treatment, Carbamazepine for pain relief, Carbamazepine for enhancing mental stability in bipolar disorder, Carbamazepine for preventing further nerve damage, Carbamazepine for improving overall patient health, Carbamazepine for controlling acute episodes of bipolar disorder, Carbamazepine for lowering risk of manic relapse, Carbamazepine for reducing facial nerve inflammation, Carbamazepine for managing post-traumatic epilepsy, Carbamazepine for stabilizing mood in treatment-resistant cases, Carbamazepine for improving seizure-free periods in epilepsy, Carbamazepine for helping with acute nerve pain, Carbamazepine for post-surgery nerve pain relief, Carbamazepine for reducing electrical activity in the brain, Carbamazepine for emotional stability in mental disorders, Carbamazepine for patients with severe psychiatric symptoms, Carbamazepine for improving mental health and quality of life, Carbamazepine for seizure activity management, Carbamazepine for controlling psychotic symptoms in bipolar disorder, Carbamazepine for easing discomfort from severe seizures, Carbamazepine for preventing mood swings and aggression in bipolar patients.
